TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
GHN Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 27 | 598 | 8 |
Financial expenses | 219 | 31 | 274 |
Earnings before taxes | -267 | 1,503 | 269 |
EBITDA | -181 | -151 | -141 |
Total assets | 8,143 | 9,245 | 7,957 |
Current assets | 216 | 331 | 381 |
Current liabilities | 19 | 33 | 52 |
Equity capital | 8,124 | 9,211 | 7,906 |
- share capital | 37 | 40 | 41 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 99.8% | 99.6% | 99.4% |
Turnover per employee | 14 | 299 | 4 |
Profit as a percentage of turnover | -988.9% | 251.3% | 3362.5% |
Return on assets (ROA) | -0.6% | 16.6% | 6.8% |
Current ratio | 1136.8% | 1003.0% | 732.7% |
Return on equity (ROE) | -3.3% | 16.3% | 3.4% |
Change turnover | -523 | 590 | -76 |
Change turnover % | -95% | 7448% | -90% |
Chg. No. of employees | 0 | 0 | 1 |
Chg. No. of employees % | 0% | 0% | 100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.